Please login to the form below

Not currently logged in
Email:
Password:

Some SkyePharma jobs saved after Swiss facility deal with Aenova

Staff retained in sub-letting contract for oral supplement

A handful of axed staff members at SkyePharma's R&D facility in Muttenz, Switzerland have managed to retain their roles after a deal with Aenova.

SkyePharma said 11 technical staff have been recruited by Aenova, with the oral supplement manufacturer sub-letting part of the Muttenz laboratories.

SkyePharma plans to reduce its staff of 101 in Muttenz by 20 per cent  to generate cost savings of £1.8m (2.6m Swiss francs) a year.

German-based Aenova said it will use the centre to expand its own oral product development activities as well as carrying out oral product formulation and analytical services for SkyePharma on a sub-contract basis.

The two companies already have a similar deal in place, with SkyePharma leasing its entire pharmaceutical manufacturing business and premises at Saint Quentin-Fallavier, Lyon, France, to Aenova.

The Lyon deal saw Aenova assume responsibility for 60 SkyePharma staff, with the company able to boost its market presence in France.

SkyePharma's CEO Peter Grant said he was pleased the deal had seen several Switzerland-based staff had been offered roles with Aenova.

He continued: “Through this further alliance we retain the capability to offer innovative oral drug delivery solutions, using the same staff on a sub-contract basis for laboratory work.

“Our Muttenz business will continue to operate competitively but with lower fixed costs, providing greater flexibility for our new business and R&D activities.”

Grant recently replaced Axel Muller as CEO, after Muller stepped down in January to “pursue other interests”.

SkyePharma said the changes at its Muttenz laboratories would not affect relationships with its customers, with the company looking to subcontract oral development and manufacturing to Aenova when appropriate.

10th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics